1. Home
  2. Standardized Extracts
  3. Yohimbe Extract
Standardized ExtractSafety-limitedAfrican traditional

Yohimbe Extract (Pausinystalia johimbe) – Yohimbine HCl 2–98%

Pausinystalia johimbe · Rubiaceae

Regulated ingredient — check your market before you buy

Restricted or safety-limited ingredient in some markets

Orders are released after a compliance review of the intended use and destination market.

Marker compound
Yohimbine HCl
Standardisation
2–98% (HPLC)
Assay method
HPLC
Plant part
Bark
Origin
Cameroon, Gabon, Nigeria

Yohimbe Extract (Pausinystalia johimbe) – Yohimbine HCl 2–98%

Yohimbe extract is produced from the bark of Pausinystalia johimbe (Rubiaceae family) and supplied as a standardized extract powder, standardized to Yohimbine HCl. Available grades: 2%, 10%, 25%, 98%. Typical sourcing: Cameroon, Gabon, Nigeria. For B2B formulation in pharmaceutical.

2%10%25%98%

Specifications

Botanical name Pausinystalia johimbe
Common names Yohimbe
Plant family / part Rubiaceae / Bark
Marker compound Yohimbine HCl
Phytochemical class Alkaloids › Indole & β-carboline alkaloids
Available grades 2%, 10%, 25%, 98%
Made-to-order grades 25% (produced on request; confirm lead time)
Assay method HPLC
Pharmacopoeia & standards USP
Form Standardized Extract
Origin Cameroon, Gabon, Nigeria
Pack sizes Sample (50 g), 250 g, 1 Kg, 5 Kg, 25 Kg; 98% grade: Sample (1 g), 50 g, 250 g, 1 Kg
Shelf life & storage Typically 24 months in sealed original packaging; store cool, dry and away from light

Regulatory status

  • Restricted or safety-limited ingredient in some markets

Supplied only to qualified business buyers for lawful manufacturing, research or pharmaceutical use. Buyers are responsible for compliance in their market.

Industries

Pharmaceutical

Documentation

The Technical Data Sheet and Safety Data Sheet (GHS format) can be downloaded from this page; the batch Certificate of Analysis is supplied on request. Confirm the assay method (HPLC, UV or gravimetric) on the CoA, as results differ between methods.

For B2B formulation and research use. Statements have not been evaluated by the FDA or other regulators; this ingredient is not intended to diagnose, treat, cure or prevent any disease.